Sale!

Cabergoline

A$95.33

-28%
Cabergoline is a medicine used to treat certain hormone-related conditions. It helps lower high levels of prolactin, which can be caused by pituitary gland problems. Some people may also use it for conditions such as Parkinson’s disease, as advised by their clinician. Cabergoline is usually taken by mouth and works gradually. Common side effects can include nausea, dizziness, headache, and sleepiness. If you feel unwell or have vision changes, seek medical advice.

Cabergoline (Cabergoline Tablets) — Patient-Friendly Guide (Australia)

Cabergoline is a medicine used to treat certain hormone-related conditions, most notably elevated prolactin levels and related disorders. This guide is written to help you understand what cabergoline does, how it works in the body, what to expect in daily life, and key safety considerations. If you have any questions about your specific situation, please speak with a qualified healthcare professional.


1) Basic Product Information

Generic name: Cabergoline

What it’s used for: Reducing excessive prolactin and treating selected pituitary and other endocrine conditions.

How it is commonly supplied: Tablets in different strengths depending on the brand and local supply.

Typical dosing schedule: Often taken once or twice weekly for some indications (your regimen may differ based on the condition).

Note: Strengths and excipients vary between brands. Always check the pack for the exact tablet strength and instructions.


2) How Cabergoline Works (Mechanism of Action)

Cabergoline belongs to a class of medicines called dopamine receptor agonists. Dopamine helps regulate the production of prolactin (a hormone made by the pituitary gland).

  • Primary mechanism: Cabergoline stimulates dopamine receptors (mainly D2) in the pituitary gland.
  • Effect on prolactin: This stimulation reduces prolactin secretion, which can improve symptoms caused by high prolactin.
  • Broader hormonal effects: By lowering prolactin, cabergoline may restore normal reproductive function, reduce milk production when unwanted, and help shrink some prolactin-secreting pituitary tumours.

3) Pharmacokinetics (What the Body Does to the Medicine)

“Pharmacokinetics” describes how the body absorbs, distributes, metabolises, and eliminates cabergoline.

  • Absorption: Cabergoline is absorbed after oral administration. Food may influence how quickly it reaches peak levels for some people.
  • Distribution: It distributes through body tissues and is highly protein-bound.
  • Metabolism: The medicine is metabolised primarily by liver pathways (commonly involving CYP-related processes).
  • Elimination: Cabergoline and its metabolites are eliminated mainly through the liver/bile and faeces, with some renal elimination.
  • Half-life and dosing frequency: Cabergoline has a long duration of action, which is one reason weekly dosing is often used for some conditions.

Individual responses vary. Your clinician may adjust your dose based on symptom relief, prolactin levels, and any side effects.


4) Typical Use and When You Might Take It

Cabergoline is used when prolactin is too high (hyperprolactinaemia) or when a prolactin-secreting pituitary tumour is suspected or confirmed. It may also be used in other endocrine settings where dopamine agonist therapy is appropriate.

Common reasons cabergoline may be prescribed

  • High prolactin levels causing symptoms such as irregular or absent periods, fertility issues, or sexual dysfunction.
  • Prolactin-secreting pituitary adenomas (microadenomas or macroadenomas) to reduce prolactin and tumour size.
  • Reducing milk production when breastfeeding is not desired (for appropriate cases).

The exact indication and treatment plan depend on your diagnosis, age, medical history, and other medications.


5) Timing & How to Take Cabergoline

Cabergoline is often prescribed as a once-weekly or twice-weekly regimen depending on the indication and dose. Some regimens also require careful titration (slow dose increases) to improve tolerability.

Practical timing tips

  • Choose a consistent day/time: For weekly dosing, pick a time you can reliably remember.
  • If twice weekly: Try to space doses evenly (for example, about 3–4 days apart) to maintain steadier effects.
  • Take with food if needed: If you experience nausea or dizziness, taking it with food may help. Discuss specific guidance with your healthcare professional.
  • Don’t double up: If you miss a dose, follow your clinician’s instructions or product guidance. Generally, do not take an extra dose to “catch up” without advice.

6) Food Interactions

Cabergoline can be affected by food in terms of absorption rate. In many people, the difference is not clinically significant, but taking with food may improve gastrointestinal comfort.

  • For nausea or stomach upset: taking the tablet with a meal or snack may be beneficial.
  • Consistency matters: if you choose to take it with food, try to keep the timing similar each week.

If you have reflux, gastritis, or other gastrointestinal conditions, let your healthcare provider know—your tolerance may change.


7) Alcohol and Medicine Interactions

Alcohol

Combining cabergoline with alcohol may increase certain side effects, particularly dizziness, sleepiness, reduced alertness, and low blood pressure (especially when you first start or when the dose changes).

  • Consider limiting or avoiding alcohol until you know how cabergoline affects you.
  • Avoid driving or operating machinery if you feel drowsy or light-headed.

Other medicines (possible interactions)

Drug interactions can occur when medicines affect dopamine pathways, blood pressure, liver metabolism, or the balance of sedation and alertness. Tell your healthcare professional about all medicines you use, including over-the-counter products and herbal supplements.

  • Antipsychotics: Some may counteract dopamine agonist effects (important for symptom control).
  • Metoclopramide or similar anti-nausea medicines: may influence dopamine signalling and could reduce effectiveness.
  • Blood pressure-lowering medicines: can increase the risk of low blood pressure, dizziness, and fainting.
  • Medicines that cause drowsiness: may add to sedation and impair alertness.
  • Caution with liver-metabolised medicines: medications that strongly affect liver enzymes may alter cabergoline levels.

This is not an exhaustive list. If you are unsure whether something interacts, check with a pharmacist.


8) Indications (What Cabergoline Is Used For)

In Australia, cabergoline is used for conditions where reducing prolactin is clinically helpful. The most common indications include:

  • Hyperprolactinaemia due to pituitary causes or other situations where prolactin is elevated.
  • Prolactin-secreting pituitary adenomas, including microadenomas and macroadenomas.
  • Galactorrhoea (abnormal milk discharge) associated with raised prolactin, depending on cause.
  • Suppression of lactation in selected circumstances (as advised by a healthcare professional).

Not all causes of high prolactin respond in the same way. Your clinician may perform blood tests and imaging studies to confirm the cause and monitor response.


9) Dosing: Typical Approaches and Dose Adjustment

Dosing depends on the indication, your prolactin level, symptom response, and tolerability. A gradual titration is common to reduce side effects such as nausea, dizziness, and low blood pressure.

Important: Always follow your personalised plan provided by your healthcare professional. The information below is general and not a substitute for individual instructions.

Common dosing patterns (general)

  • Starting dose: Often low, then slowly increased every few weeks as needed.
  • Maintenance dose: Usually the lowest effective dose that controls prolactin and symptoms.
  • Weekly/twice-weekly regimen: Many patients take cabergoline once or twice weekly.

Monitoring and dose adjustments

  • Prolactin blood tests: may be repeated after starting and during dose changes to confirm effectiveness.
  • Symptom tracking: menstrual regularity, fertility signs, headaches, and sexual function may be monitored.
  • Imaging (if applicable): for pituitary tumours, doctors may use MRI scans at intervals to assess changes.

10) Safety Profile and Important Precautions

Most people tolerate cabergoline, but like all medicines, it can cause side effects. Some effects are more likely at the start of treatment or after dose increases.

Common side effects

  • Nausea
  • Dizziness or light-headedness
  • Headache
  • Fatigue or sleepiness
  • Low blood pressure (sometimes especially when standing up)
  • Stomach upset
  • Constipation (in some people)

Less common but important risks

  • Sleepiness and sudden sleep onset: Some dopamine agonists can cause unexpected sleepiness. Avoid driving or operating machinery if you feel unusually drowsy.
  • Behavioural changes: Rarely, impulse control problems (such as increased gambling urges or compulsive behaviours) have been reported with dopamine agonists. Seek medical advice if you notice changes.
  • Heart valve and fibrotic disorders (rare): Dopamine agonists have been associated with fibrotic/valvular changes, particularly with long-term use at higher cumulative doses. Clinicians may consider baseline and follow-up assessments depending on your situation.
  • Psychiatric symptoms: mood changes may occur; report new or worsening symptoms.

When to seek urgent help

Get urgent medical attention if you experience:

  • Fainting or severe dizziness
  • Chest pain, shortness of breath, or abnormal heart symptoms
  • Severe headaches with neurological symptoms (e.g., weakness, vision changes)
  • Severe allergic reactions (swelling of face/lips, difficulty breathing, rash)

11) Practical Use Tips (How to Improve Your Experience)

  • Start low, go slow: If your dose is being increased, follow the titration schedule—this improves tolerability.
  • Stand up slowly: This can reduce dizziness from low blood pressure. Take care especially after the first dose and after dose increases.
  • Keep a symptom diary: Note timing of doses and any side effects; it helps clinicians fine-tune treatment.
  • Stay hydrated: Dehydration can worsen dizziness and low blood pressure.
  • Be cautious with driving: If you feel sleepy, delay driving until you feel fully alert.
  • Don’t stop suddenly: Unless advised by your healthcare professional, avoid abrupt discontinuation—prolactin may rise again.
  • Attend monitoring: Regular follow-up supports safe and effective treatment.

12) Alternative Options

Alternatives depend on your specific diagnosis, medical history, and the cause of high prolactin. Options may include:

Other dopamine agonists

  • Quinagolide (where available/appropriate)
  • Cabergoline alternatives within the dopamine agonist class may be considered if cabergoline is not suitable or not tolerated

Other management approaches

  • Observation and monitoring for mild cases depending on tumour size and symptom burden
  • Surgery (for selected pituitary tumours or cases where medication is not effective)
  • Radiotherapy in certain long-term or refractory scenarios
  • Treating underlying causes if prolactin elevation is due to another condition (for example, medication-induced or hypothyroidism)

Your clinician can explain the risks and benefits of each option in your context.


13) Market & Legal Context for Australia (Plain-Language Overview)

In Australia, access to medicines is regulated to support safe use. Cabergoline is subject to the country’s medicines classification and dispensing rules. Availability may vary by supplier and formulation strength.

  • Therapeutic guidance: Healthcare professionals use clinical guidelines and prescribing information when selecting therapy.
  • Quality and supply: Reputable suppliers follow storage and handling requirements for medicine integrity.
  • Safety monitoring: Because of potential risks and the need for effectiveness monitoring, follow-up testing may be recommended.

Product availability and listing status can change over time. If you cannot find a particular strength, you can ask a pharmacist about substitutions or ordering options (where permitted).


14) Recent Guidance & Monitoring Notes (General)

Clinical practice for dopamine agonists continues to emphasise safe dosing, careful titration, and monitoring for effectiveness and tolerability. Recent practice in many settings includes:

  • Individual risk assessment for heart valve/fibrotic effects, particularly with longer-term use.
  • Periodic prolactin measurement to ensure biochemical control.
  • Monitoring symptoms such as headaches or visual changes if a pituitary lesion is involved.
  • Patient education about side effects like dizziness, sleepiness, and impulse-control changes.

Guidance may differ depending on local protocols and your personal medical history.


15) Delivery and Availability (Online Pharmacy Considerations in Australia)

Cabergoline availability can depend on stock levels, tablet strengths, and supply chains. If ordering online, ensure you select the correct strength and check the product label carefully.

What to expect

  • Order processing: Orders are typically processed during business hours.
  • Packaging: Medicines should be delivered in secure, manufacturer-compliant packaging.
  • Delivery timeframe: Delivery times vary by location and service level.
  • Storage on arrival: Store tablets according to the pack instructions, usually in a cool, dry place away from moisture and heat.

If you have urgent needs or specific dosing schedules, place orders early and confirm expected delivery dates with the pharmacy.


16) Cabergoline FAQ

How long does it take cabergoline to work?

Many people notice symptom improvement within days to weeks, while prolactin levels may take longer and are often checked after a period of treatment. Your clinician will advise when to repeat blood tests.

Can I take cabergoline with food?

Yes, many people can take cabergoline with food, and this may help reduce nausea. Try to keep your routine consistent.

What should I do if I miss a dose?

Because cabergoline is often taken weekly, missing doses should be handled carefully. Follow the instructions provided by your healthcare professional or the product guidance. If you’re unsure, contact your pharmacist for advice.

Can I drink alcohol while taking cabergoline?

Alcohol may increase dizziness and sleepiness. It’s best to limit alcohol and avoid driving or risky activities if you feel drowsy or light-headed.

Is cabergoline safe for long-term use?

Many patients use cabergoline long-term under medical supervision, particularly for chronic hormone conditions. Long-term safety includes monitoring for potential rare effects such as heart valve/fibrotic changes, as clinically appropriate.

Who should be extra careful with cabergoline?

Extra caution may be needed if you have low blood pressure, heart valve disease, liver problems, severe psychiatric history, or if you are taking medicines that affect dopamine pathways or blood pressure. Discuss your full medication list with your healthcare professional.

Does cabergoline affect fertility?

By lowering prolactin, cabergoline may improve reproductive function in people whose fertility issues are related to elevated prolactin. If pregnancy is a possibility, discuss timing and monitoring with your clinician.

What side effects are most common?

Nausea, dizziness, headache, fatigue, and sometimes low blood pressure are among the more common side effects—especially early in treatment or after dose changes.


17) Summary Table (Quick Reference)

Topic Key Points
Medicine Cabergoline (dopamine receptor agonist)
Main benefit Reduces excess prolactin and may shrink prolactin-secreting pituitary tumours
Typical schedule Often once or twice weekly, depending on your indication and dose
How it works Stimulates dopamine receptors to decrease prolactin release
Food interaction May be taken with food if it helps nausea; consistency is helpful
Alcohol May increase dizziness/sleepiness—limit alcohol and avoid driving if drowsy
Key side effects Nausea, dizziness, headache, fatigue; low blood pressure may occur
Important cautions Sleepiness, impulse-control changes (rare), and rare heart valve/fibrotic risks in long-term use
Monitoring Prolactin blood tests and clinical follow-up; imaging if a pituitary tumour is involved

Final Note

Cabergoline can be an effective treatment for conditions driven by high prolactin. Success often depends on finding the right dose, taking it consistently, and attending recommended monitoring. If you experience troubling side effects or new symptoms, contact a healthcare professional promptly. For day-to-day support—such as how to manage missed doses, nausea, or missed follow-ups—your pharmacist can help.

Additional information

Dosage: No selection

0,25mg, 0,5mg

Package: No selection

8 pill, 12 pill, 16 pill, 20 pill, 32 pill